Try our Advanced Search for more refined results
Searching dockets in Pierce Atwood x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent | Massachusetts
Declaration
DECLARATION re 817 Memorandum in Opposition to Motion, Declaration of Frederick J. Ding by Abiomed Europe GmbH, Abiomed Inc., Abiomed R&D, Inc.. (Attachments: # 1 Exhibit TX0106 - EPR File History, # 2 Exhibit TX4001 - Siess 913 Patent, # 3 Exhibit TX4003 - Flameng, # 4 Exhibit TX4006 - Siess 685 Patent, # 5 Exhibit TX4030 - Siess 948 Patent, # 6 Exhibit A - 5/13 Trial Transcript, # 7 Exhibit B - 5/14 Trial Transcript, # 8 Exhibit C - 5/15 Trial Transcript, # 9 Exhibit D - 5/18 Trial Transcript, # 10 Exhibit E - 5/20 Trial Transcript, # 11 Exhibit F - 5/21 Trial Transcript, # 12 Exhibit G - 5/22 Trial Transcript, # 13 Exhibit H - 5/26 Trial Transcript)(Ding, Frederick)
Memorandum in Opposition to Motion
MEMORANDUM in Opposition re 811 MOTION for Judgment as a Matter of Law Renewed Motion for Judgment as a Matter of Law Under Rule 50(b), or in the Alternative, for a New Trial Under Rule 59 filed by Abiomed Europe GmbH, Abiomed Inc., Abiomed R&D, Inc.. (Matty, Brian)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.